Q3 2024 Holdings
Filed 2024-11-14 | 16 holdings | $201.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $50.1M | 92,500 | 24.9% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $34.8M | 663,381 | 17.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $27.2M | 1,504,307 | 13.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $24.6M | 466,813 | 12.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $18.8M | 209,632 | 9.3% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $14.4M | 1,100,000 | 7.2% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $10.8M | 240,000 | 5.4% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $4.3M | 380,000 | 2.1% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $4.1M | 825,341 | 2.0% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $3.1M | 1,736,477 | 1.5% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $2.9M | 57,983 | 1.5% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $2.0M | 182,426 | 1.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $1.9M | 157,514 | 1.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $1.3M | 25,543 | 0.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $835.0K | 250,000 | 0.4% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $424.6K | 649,957 | 0.2% |